126 related articles for article (PubMed ID: 11205290)
1. Thymic humoral factor-gamma 2 augments immune cell response and exerts antitumor activity in murine model systems.
Beuth J; Schierholz JM; Mayer G; Keisari Y
Anticancer Res; 2000; 20(6B):4473-6. PubMed ID: 11205290
[TBL] [Abstract][Full Text] [Related]
2. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice.
Beuth J; Schierholz JM; Ko HL; Braun JM
In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237
[TBL] [Abstract][Full Text] [Related]
3. Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.
Braun JM; Ko HL; Schierholz JM; Beuth J
Anticancer Res; 2002; 22(6C):4187-90. PubMed ID: 12553054
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulating and antimetastatic activity of thymic peptides in BALB/c mice.
Beuth J; Schierholz JM; Mayer G
Anticancer Res; 1999; 19(4B):2993-5. PubMed ID: 10652583
[TBL] [Abstract][Full Text] [Related]
5. Thymosin alpha(1) application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice.
Beuth J; Schierholz JM; Mayer G
Cancer Lett; 2000 Oct; 159(1):9-13. PubMed ID: 10974400
[TBL] [Abstract][Full Text] [Related]
6. Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapy.
Ophir R; Pecht M; Keisari Y; Rashid G; Lourie S; Meshorer A; Ben-Efraim S; Trainin N; Burstein Y
Immunopharmacol Immunotoxicol; 1996 May; 18(2):209-36. PubMed ID: 8771368
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.
Schaffrath B; Mengs U; Schwarz T; Hilgers RD; Beuth J; Möckel B; Lentzen H; Gerstmayer B
Anticancer Res; 2001; 21(6A):3981-7. PubMed ID: 11911280
[TBL] [Abstract][Full Text] [Related]
8. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics in antitumor effects of organic silicon related compounds].
Fukushima K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2173-81. PubMed ID: 2544147
[TBL] [Abstract][Full Text] [Related]
10. Modulation of murine tumor growth and colonization by bromelaine, an extract of the pineapple plant (Ananas comosum L.).
Beuth J; Braun JM
In Vivo; 2005; 19(2):483-5. PubMed ID: 15796214
[TBL] [Abstract][Full Text] [Related]
11. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
Li Y; Tang ZY; Wang L; Yao Z; Lu R; Xue Q; Gao DM; Chen J
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):675-9. PubMed ID: 15130313
[TBL] [Abstract][Full Text] [Related]
12. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
Shanker A; Singh SM
Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
[TBL] [Abstract][Full Text] [Related]
13. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
[TBL] [Abstract][Full Text] [Related]
14. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
15. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
Orsolić N; Basić I
Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
[TBL] [Abstract][Full Text] [Related]
16. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites.
Sasaki H; Schmitt D; Hayashi Y; Pollard RB; Suzuki F
Nat Immun; 1993; 12(2):104-12. PubMed ID: 8318815
[TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
[TBL] [Abstract][Full Text] [Related]
19. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
20. Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems.
Beuth J; Ko HL; Gabius HJ; Pulverer G
In Vivo; 1991; 5(1):29-32. PubMed ID: 1932621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
